Prothena Corp Public (PRTA) Accumulated Depreciation & Amortization (2012 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Accumulated Depreciation & Amortization of $184000.0 in Q1 2026, down 79.44% quarter-over-quarter from $895000.0 in Q4 2025, and down 17.49% on a YoY basis from $223000.0 in Q1 2025.

Prothena Corp Public (PRTA) Accumulated Depreciation & Amortization (2012 - 2026) Analysis & Trends

Prothena Corp Public's Accumulated Depreciation & Amortization history runs 15 years deep, the most recent figure standing at $184000.0 for Q1 2026.

  • In Q1 2026, Accumulated Depreciation & Amortization fell 17.49% year-over-year to $184000.0; the TTM figure through Mar 2026 stood at $184000.0 (down 17.49% YoY), while the FY2025 annual figure was $895000.0, changed 0.22% from the prior year.
  • Accumulated Depreciation & Amortization was $184000.0 for Q1 2026 at Prothena Corp Public, down from $895000.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $928000.0 in Q4 2023 to a low of $182000.0 in Q1 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $511588.2 across 5 years, with a median of $448000.0 in 2025.
  • The sharpest annual moves came in 2022 and 2023: Accumulated Depreciation & Amortization tumbled 40.13% in 2022, then rose 24.73% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $744000.0 in 2022, then grew by 24.73% to $928000.0 in 2023, then retreated by 3.77% to $893000.0 in 2024, then advanced by 0.22% to $895000.0 in 2025, then sank by 79.44% to $184000.0 in 2026.
  • The last three Accumulated Depreciation & Amortization figures came in at $184000.0 (Q1 2026), $895000.0 (Q4 2025), and $677000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Prothena Corp Public 459.74 Mn 130.28 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 184,000.00
Mar 31, 2026 184,000.00
Dec 31, 2025 895,000.00
Dec 31, 2025 895,000.00
Sep 30, 2025 677,000.00
Sep 30, 2025 677,000.00
Jun 30, 2025 448,000.00
Jun 30, 2025 448,000.00
Mar 31, 2025 223,000.00
Mar 31, 2025 223,000.00
Dec 31, 2024 893,000.00
Dec 31, 2024 893,000.00
Sep 30, 2024 672,000.00
Sep 30, 2024 672,000.00
Jun 30, 2024 446,000.00
Jun 30, 2024 446,000.00
Mar 31, 2024 215,000.00
Mar 31, 2024 215,000.00
Dec 31, 2023 928,000.00
Dec 31, 2023 928,000.00